project

STEM-PD

An investigational allogeneic cell therapy for Parkinson's disease designed to replace dopamine-producing neurons, carrying FDA IND clearance and Fast Track designation.

Current clusters

invest2 publishers

Novo Nordisk took equity in the buyer of the Parkinson's therapy it shelved

Cellular Intelligence has added Bob Langer and Yann LeCun to its scientific advisory board. The $62m to $70m it has raised now has to take STEM-PD, the cell therapy Novo Nordisk dropped, through Phase 2.

Publishers:cryptobriefing.comfortune.com

Reality

Evidence45
Adoption32
Hype gap+38
Incentives72
Confidence58